PRIME CAPITAL INVESTMENT ADVISORS, LLC – Eli Lilly and Company Transaction History
PRIME CAPITAL INVESTMENT ADVISORS, LLC portfolio value:
$6.88M
portfolio value
PRIME CAPITAL INVESTMENT ADVISORS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +56.12% | 7.65K shares | 2.46M | $323.35 | 21.29K |
| Q2 2022 | share | Decrease | -23.96% | -4.29K shares | -533K | $324.23 | 13.63K |
| Q1 2022 | share | Decrease | -1.15% | -209 shares | -57K | $286.37 | 17.93K |
| Q4 2021 | share | Increase | +92.81% | 8.73K shares | 2.83M | $277.25 | 18.14K |
| Q3 2021 | share | Decrease | -62.02% | -15.36K shares | -3.51M | $230.3 | 9.41K |
| Q2 2021 | share | Increase | +8.72% | 1.98K shares | 1.42M | $228.04 | 24.77K |
| Q1 2021 | share | Increase | +117.26% | 12.30K shares | 2.48M | $184.81 | 22.79K |
| Q4 2020 | share | Increase | 0.00% | 10.49K shares | 1.77M | $166.32 | 10.49K |
| Q3 2020 | share | Decrease | -100.00% | -797 shares | -131K | $145.05 | 0 |
| Q2 2020 | share | Decrease | -21.94% | -224 shares | -11K | $160.1 | 797 |
| Q1 2020 | share | Decrease | -18.32% | -229 shares | -22K | $134.64 | 1.02K |
| Q4 2019 | share | Decrease | -0.64% | -8 shares | 23K | $126.91 | 1.25K |
| Q3 2019 | share | Increase | 0.00% | 1.25K shares | 141K | $107.36 | 1.25K |
| Q1 2019 | share | Decrease | -100.00% | -538 shares | -62K | $123.17 | 0 |
| Q4 2018 | share | Increase | +438.00% | 438 shares | 51K | $109.26 | 538 |
| Q3 2018 | share | Decrease | -66.67% | -200 shares | -15K | $100.8 | 100 |
| Q2 2018 | share | 0.00% | 0 shares | 3K | $79.72 | 300 | |
| Q1 2018 | share | Increase | 0.00% | 300 shares | 23K | $71.78 | 300 |